BioChainbreast cancer
…in’s spatial transcriptomics platform. These findings establish BioChain as a premier CRO partner for oncology programs seeking scalable…
11,350articles mentioning institutions
22,378institution mentions
9,137distinct institutions extracted
0%of mentions human-reviewed
All extracted institutions
Showing 1,981–2,040 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
A&E1ACCORD1ADSTILADRIN1AGENAS1AGU1AIC Kijabe Hospital1AKUH1ALERT Comprehensive Specialised Hospital1ALSWH1AMBOSS1ANRS-PREVENIR1ANZCRT1APPAC IV1ATC group C071AZUR-21Aalen University1Agogo Presbyterian Hospital1Albany Medical College1Aliment Pharmacol Ther1Allegheny Health1AllofUS1Alomone Labs1American Dental Association1American Journal of Gastroenterology1American Society of Transplantation1Amiens-Picardie University Hospital1Aneuvas Technologies, Inc1Archambault et al1Arm 31Asociación Latinoamericana para el Estudio del Hígado1AstraZeneca1Atrium Health Carolinas Medical Center1BD Biosciences1BE MOBILE 11BIDMC1BIOME study1BMHI1BSGE1BSU1BabyGel trial1Baxter et al1Beijing1Beijing Friendship Hospital1Beijing Huilongguan Hospital1Benchmark-SLE1BioMedware1BioMere1BornFyne1Boston University Medical Center1Brain Aneurysm Foundation1Brain-Heart team1Brightline1Bristol Myers Squibb1British Menopause Society1BronchUK Registry1Brown University Health Institutional Review Board1C-STACS1CAMP1CANN20211CASEM1
Articles mentioning institutions
11,350 articles · page 308 of 946Thomas Jefferson Universitynon-small cell lung cancertriple-negative breast cancercolorectal cancermelanomaipilimumabnivolumabDetermaIO
… was reviewed and approved by the Institutional Review Board at Thomas Jefferson University (IRB#iRISID-2024-1601). The participants gave informed consent …
The Cancer Genome Atlaspembrolizumabmetastatic colorectal cancer
… a five-year disease-free survival rate of 100% in stage II. In The Cancer Genome Atlas gastric cohort, tumors with high tumor mutational burden showed…
National Institutes of HealthNIHHNSCCcuSCCPembrolizumabIRDye®700DXASP-1929ASP-1929 PIT
… for HNSCC and cuSCC.Ethics Approval This study was approved by National Institutes of Health (NIH) Institutional Review Board; IRB number 000462.Participant…
76.7%
Institutional Review BoardInstitutional Animal Care and Use CommitteeNALM-6
…MC collection from healthy donors was performed according to an Institutional Review Board approved protocol. UVA-HSR-IRB #18842 All animal studies were c…
University of Wisconsin-MadisonNeuroblastomaGD2BBDAP12CAR-T cell therapyGD2BBζ
…urable responses.Ethics Approval This study was approved by the University of Wisconsin-Madison Institutional Review Board (protocol #2017-1070) for the use of…
University of Maryland, BaltimoreATCCprostate cancerCAR T-cell therapyPSMA
…in mice was approved by Institutional IACUC review committee at University of Maryland, Baltimore (IACUC protocol no. 1021001: amendment #81). Efficacy study in …
Boston Children’s Hospital Animal FacilityUniversity of TurinlorlatinibMerkel cell carcinomaMCCneuroblastomanadelalkib
…ChBU n. 1–2022). The animal study was approved and conducted at Boston Children’s Hospital Animal Facility (protocol n. 00002434).Abstract 225 Figure 1ALK+ MCC models cha…
Stemcell TechnologiesNat Rev Immunolsolid tumorsHNSCC
…wo days (chronic stimulation) using CD2/3/28 antibody cocktail (Stemcell Technologies) as described previously to simulate TEX. 3 After 6-10 days of …
Dana-Farber Cancer InstituteBrigham and Women’s Hospital Crimson Coresolid tumorshuman cancersPC3 prostate cancerhuman prostate cancerCARM1
…ormed in accordance with protocol 08-049 as was approved by the Dana-Farber Cancer Institute Institutional Animal Care and Use Committee (IACUC). Human PBMC…
NSGSCID-Beige xenograft mouse modelssolid tumorstype I interferonImmune-based therapies
…ulatory potential were selected for in vivo evaluation. In both NSG and SCID-Beige xenograft mouse models, CAR-T cells expressing t…